An LC–MS/MS method for serum cystatin C quantification and its comparison with two commercial immunoassays
Li Zhang,Xiaerbanu Nizhamuding,Hao Zheng,Jie Zeng,Xinyi Yuan,Zijia Ma,Weiyan Zhou,Chao Zhang,Tianjiao Zhang,Chuanbao Zhang
DOI: https://doi.org/10.1515/cclm-2023-0821
2024-01-23
Clinical Chemistry and Laboratory Medicine (CCLM)
Abstract:The standardization of cystatin C (CysC) measurement has received increasing attention in recent years due to its importance in estimating glomerular filtration rate (GFR). Mass spectrometry-based assays have the potential to provide an accuracy base for CysC measurement. However, a precise, accurate and sustainable LC–MS/MS method for CysC is still lacking. The developed LC–MS/MS method quantified CysC by detecting signature peptide (T3) obtained from tryptic digestion. Stable isotope labeled T3 peptide (SIL-T3) was spiked to control matrix effects and errors caused by liquid handling. The protein denaturation, reduction and alkylation procedures were combined into a single step with incubation time of 1 h, and the digestion lasted for 3.5 h. In the method validation, digestion time-course, imprecision, accuracy, matrix effect, interference, limit of quantification (LOQ), carryover, linearity, and the comparability to two routine immunoassays were evaluated. No significant matrix effect or interference was observed with the CysC measurement. The LOQ was 0.21 mg/L; the within-run and total imprecision were 1.33–2.05 % and 2.18–3.90 % for three serum pools (1.18–5.34 mg/L). The LC–MS/MS method was calibrated by ERM-DA471/IFCC and showed good correlation with two immunoassays traceable to ERM-DA471/IFCC. However, significant bias was observed for immunoassays against the LC–MS/MS method. The developed LC–MS/MS method is robust and simpler and holds the promise to provide an accuracy base for routine immunoassays, which will promote the standardization of CysC measurement.
medical laboratory technology